Nektar Therapeutics (NKTR) Social Stream
NEKTAR THERAPEUTICS (NKTR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering NKTR.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-28 | 8 | $29 | $18 | $21.444 | $0.54 | 3871.11% |
| 2022-03-01 | 8 | $29 | $17 | $20.666 | $0.54 | 3727.04% |
| 2022-03-02 | 9 | $29 | $17 | $20.777 | $0.54 | 3747.59% |
| 2022-03-09 | 9 | $29 | $12 | $19.888 | $0.54 | 3582.96% |
| 2022-03-15 | 10 | $29 | $5 | $12.555 | $0.54 | 2225% |
| 2022-04-18 | 10 | $29 | $4.7 | $12.077 | $0.54 | 2136.48% |
| 2022-04-25 | 10 | $29 | $4.7 | $11.966 | $0.54 | 2115.93% |
| 2022-05-06 | 10 | $20 | $4.7 | $9.837 | $0.54 | 1721.67% |
| 2022-05-17 | 10 | $20 | $4.6 | $9.7 | $0.54 | 1696.3% |
| 2022-05-31 | 10 | $20 | $4 | $8.7 | $0.54 | 1511.11% |
| 2022-06-08 | 10 | $20 | $4 | $8.575 | $0.54 | 1487.96% |
| 2022-08-08 | 9 | $6 | $4 | $4.766 | $0.54 | 782.59% |
| 2022-09-17 | 8 | $6 | $4 | $4.783 | $0.54 | 785.74% |
| 2022-11-07 | 9 | $6 | $4 | $4.783 | $0.54 | 785.74% |
| 2023-02-08 | 9 | $6 | $3.2 | $4.65 | $0.54 | 761.11% |
| 2023-02-26 | 10 | $6 | $1.5 | $3.7 | $0.54 | 585.19% |
| 2023-02-27 | 10 | $6 | $1.5 | $3.457 | $0.54 | 540.19% |
| 2023-03-01 | 10 | $6 | $1.5 | $3.214 | $0.54 | 495.19% |
| 2023-03-31 | 9 | $6 | $1.5 | $2.928 | $0.54 | 442.22% |
| 2023-04-05 | 10 | $6 | $1.5 | $2.928 | $0.54 | 442.22% |
| 2023-04-27 | 10 | $6 | $1.5 | $2.714 | $0.54 | 402.59% |
| 2023-05-01 | 10 | $6 | $0.7 | $2.528 | $0.54 | 368.15% |
| 2023-06-06 | 9 | $6 | $0.7 | $2.366 | $0.54 | 338.15% |
| 2023-09-28 | 8 | $6 | $0.6 | $2.35 | $0.54 | 335.19% |
| 2023-11-08 | 7 | $5 | $0.5 | $2.025 | $0.54 | 275% |
The Trend in the Analyst Price Target
NKTR's average price target has moved down $19.34 over the prior 22 months.
NKTR reports an average of 209.58% for its upside potential over the past 41 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-31 | 9 | 6 | 1.5 | 2.928 | 0.703 | 316.5% |
| 2023-05-01 | 9 | 6 | 0.7 | 2.528 | 0.773 | 227.04% |
| 2023-05-15 | 9 | 6 | 0.7 | 2.366 | 0.763 | 210.09% |
| 2023-06-02 | 9 | 6 | 0.7 | 2.366 | 0.619 | 282.23% |
| 2023-11-08 | 7 | 5 | 0.5 | 2.025 | 0.500 | 305% |
NKTR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.14 | 1 | 0 | 4 | 1 | 1 | 7 |
The Trend in the Broker Recommendations
NKTR's average broker recommendation rating improved by 0.3 over the prior 39 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NKTR as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, NEKTAR THERAPEUTICS's upside potential (average analyst target price relative to current price) is higher than 3058.96% of them.
- NEKTAR THERAPEUTICS's average analyst price target is greater than 245.18% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the large market cap category, NEKTAR THERAPEUTICS's variance in analysts' estimates is lower than -2747.64% of them.
- NEKTAR THERAPEUTICS's number of analysts covering the stock is greater than 690.39% of stocks in the large market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to NEKTAR THERAPEUTICS are BHC, VRTX, and IONS.
View All Top Stocks by Price Target
What is the outlook for NKTR? Use POWR Ratings for clearer insight into price direction.